5 Largest Psychedelic Compound-Based Drug Stocks Up 17% Last Week

Chart, Trading, Forex, Analysis, Tablet, Pc

Image Source: Pixabay
 

The 5 constituents in the munKNEE Psychedelic Drug Stocks Index jumped 16.7%, on average, last week and are now up 11.7% MTD. Below is how each constituent stock performed last week, in descending order, and MTD, and any recent  news, commentary, and/or analysis on each company:

  1. Compass Pathways (CMPS): UP 33.1% last week; UP 22.2% MTD
    • is focused on the use of psilocybin (magic mushrooms) in their research. Go here for much more extensive information on Psilocybin.
    • Latest News, Commentary and/or Analysis:
      • None
  2. GH Research (GHRS): UP 23.9% last week; UP 25.0% MTD
  3. Mind Medicine (MNMD): UP 2.8% last week; UP 0.8% MTD
  4. Atai Life Sciences (ATAI): UP 1.2% last week; UP 22.0% MTD
    • is focused on the use of ketamine, DMT and ibogaine.  Go here for much more extensive information on Ketamine and here for much more extensive information on DMT.
    • Latest News, Commentary and/or Analysis:
      • None
  5. Incannex Healthcare (IXHL): DOWN 7.4% last week; DOWN 19.4% MTD

Summary

The munKNEE Psychedelic Drug Stocks Index went UP 16.7% last week and is now up 11.7% MTD.


More By This Author:

Quantum Computing Hardware Developers Index Up Last Week
Conservative "Cannabis" Stocks Down Last Week; What You Need To Know
These 7 Cannabis MSO Stocks Advanced 5% Last Week

Disclosure: None

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.